ticker nerd logo
Exponent Inc

Exponent Inc Stock Forecast & Price Prediction

Live Exponent Inc Stock (EXPO) Price
$114.63

4

Ratings

  • Buy 1
  • Hold 3
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$114.63

P/E Ratio

56.47

Volume Traded Today

$130,100

Dividend

$0.28

52 Week High/low

115.62/64.61

Exponent Inc Market Cap

$5.82B

🛑 Alert: These ten stocks could have higher potential than $EXPO 🛑

Before you buy EXPO you'll want to see this list of ten stocks that have huge potential. Want to see if EXPO made the cut? Enter your email below

EXPO Summary

The Exponent Inc (EXPO) share price is expected to increase by 0.32% over the next year. This is based on calculating the average 12-month share price estimate provided by 4 stock analysts who have covered EXPO. Price targets range from $110 at the low end to $120 at the high end. The current analyst consensus for EXPO is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

EXPO Analyst Ratings

Exponent Inc has a total of 4 Wall St Analyst ratings. There are 1 buy ratings, 3 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Exponent Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

EXPO stock forecast by analyst

These are the latest 20 analyst ratings of EXPO.

Analyst/Firm

Rating

Price Target

Change

Date

Tobey Sommer
Truist Securities

Buy

$120

Reiterates

Jul 26, 2024
Tobey Sommer
Truist Securities

Buy

$100

Maintains

Apr 29, 2024
Tobey Sommer
Truist Securities

Buy

$95

Maintains

Feb 2, 2024
Tobey Sommer
Truist Securities

Buy

$110

Maintains

Jul 31, 2023
Joshua Chan
UBS

Neutral

$99

Initiates

Jun 1, 2023
Tobey Sommer
Truist Securities

Buy

$120

Maintains

Apr 5, 2022
Tobey Sommer
Truist Securities

Buy

$118

Maintains

Aug 2, 2021

Sidoti & Co.

Buy

$94

Maintains

Jun 2, 2020

Sidoti & Co.

Buy


Upgrade

May 13, 2020

Sidoti & Co.

Neutral

$80

Maintains

May 1, 2020
Marc Riddick
Sidoti & Co.

Buy

$78

Upgrade

Mar 19, 2020

Sidoti & Co.

Neutral

$74

Maintains

Feb 7, 2020

Sidoti & Co.

Neutral

$72

Maintains

Oct 3, 2019

SunTrust Robinson Humphrey

Buy

$81

Maintains

Sep 20, 2019

DA Davidson

Neutral


Initiates

Aug 29, 2019

SunTrust Robinson Humphrey

Buy


Upgrade

Jan 26, 2018

Cantor Fitzgerald

Buy


Initiates

Aug 26, 2016

EXPO Company Information

What They Do: Provides science and engineering consulting services.

Business Model: Exponent, Inc. operates as a consulting firm, offering specialized services in engineering and environmental health across various sectors. The company generates revenue by charging clients for its expertise in approximately 90 technical disciplines, addressing complex challenges in industries such as chemical, construction, and life sciences.

Other Information: Founded in 1967 and headquartered in Menlo Park, California, Exponent has a long history in the consulting field. The company serves a diverse array of clients, reflecting its broad range of services in both engineering and environmental health, positioning it well for growth in various sectors.
EXPO
Exponent Inc (EXPO)

When did it IPO

1990

Staff Count

975

Country

United States

Sector/Industry

Industrials/Engineering & Construction

CEO

Dr. Catherine Ford Corrigan P.E., Ph.D.

Market Cap

$5.82B

Exponent Inc (EXPO) Financial Data

In 2023, EXPO generated $536.8M in revenue, which was a increase of 4.57% from the previous year. This can be seen as a signal that EXPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$399.9M

Revenue From 2021

$466.3M

16.60 %
From Previous Year

Revenue From 2022

$513.3M

10.09 %
From Previous Year

Revenue From 2023

$536.8M

4.57 %
From Previous Year
  • Revenue TTM $508.5M
  • Operating Margin TTM 27.0%
  • Gross profit TTM $0
  • Return on assets TTM 11.3%
  • Return on equity TTM 27.9%
  • Profit Margin 20.6%
  • Book Value Per Share 7.75%
  • Market capitalisation $5.82B
  • Revenue for 2021 $466.3M
  • Revenue for 2022 $513.3M
  • Revenue for 2023 $536.8M
  • EPS this year (TTM) $2.03

Exponent Inc (EXPO) Latest News

News Image

Wed, 18 Sep 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - Exponent (EXPO) and Cellebrite DI Ltd. (CLBT) have shown performance metrics relative to their sector this year. Further details on specific performance metrics were not provided.

Why It Matters - Performance comparisons highlight relative strength or weakness, influencing investor sentiment and potential investment decisions for Exponent and Cellebrite relative to their sector.

News Image

Tue, 30 Jul 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - Exponent (EXPO) shares are gaining momentum, supported by positive earnings estimate revisions, suggesting potential for further price increases in the near term.

Why It Matters - Rising earnings estimate revisions for Exponent (EXPO) suggest improving financial performance, potentially driving share price appreciation and attracting investor interest.

News Image

Thu, 01 Aug 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - The Zacks Consulting Services industry is set for growth due to strong service activities, with IT, FCN, and EXPO identified as key stocks to benefit from this demand.

Why It Matters - Healthy service activities indicate robust demand, suggesting potential growth for Zacks Consulting Services stocks like IT, FCN, and EXPO, which may attract investor interest and drive stock prices up.

News Image

Thu, 25 Jul 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - Exponent, Inc. (NASDAQ:EXPO) held its Q2 2024 Earnings Conference Call on July 25, 2024, featuring CEO Catherine Corrigan and CFO Rich Schlenker. Participants included analysts from William Blair, UBS, and Truist.

Why It Matters - The earnings call provides insights into Exponent's financial performance and strategic direction, influencing investor sentiment and stock valuation.

News Image

Thu, 25 Jul 2024

Sentiment - NEUTRAL

Source - GlobeNewsWire

Summary - Exponent, Inc. (Nasdaq: EXPO) will pay a quarterly cash dividend of $0.28 per share on September 20, 2024, to shareholders recorded by September 6, 2024.

Why It Matters - Exponent, Inc.'s declaration of a quarterly cash dividend signals financial stability and commitment to returning value to shareholders, potentially boosting investor confidence and stock demand.

News Image

Thu, 25 Jul 2024

Sentiment - NEUTRAL

Source - GlobeNewsWire

Summary - Exponent, Inc. (Nasdaq: EXPO) announced its Q2 fiscal 2024 financial results for the period ending June 28, 2024. Further details on performance were not provided in the excerpt.

Why It Matters - Exponent, Inc.'s Q2 financial results can impact stock performance, indicating the company's growth, profitability, and market position, influencing investor sentiment and decisions.

...

EXPO Frequently asked questions

The highest forecasted price for EXPO is $120 from Tobey Sommer at Truist Securities.

The lowest forecasted price for EXPO is $110 from Tobey Sommer from Truist Securities

The EXPO analyst ratings consensus are 1 buy ratings, 3 hold ratings, and 0 sell ratings.